Figure 1 Western Blot Validation of MyD88 in human cell lines
Loading: 15 μg of lysates per lane.
Antibodies: 2127 (2 μg/mL) 1 h incubation at RT in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Predicted band size: 35 kDa
Figure 2 Independent Antibody Validation (IAV) via Protein Expression Profile in Cell Lines
Loading: 15 μg of lysates per lane.
Antibodies: MyD88 2125 (2 μg/mL), MyD88 2127 (2 μg/mL), beta-actin (1 μg/mL), and GAPDH (0.02 μg/mL), 1 h incubation at RT in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Figure 3 Independent Antibody Validation (IAV) via Protein Expression Profile in Human Tissues
Loading: 15 μg of lysates per lane.
Antibodies: MyD88 2125 (2 μg/mL), MyD88 2127 (2 μg/mL), beta-actin (1 μg/mL), and GAPDH (0.02 μg/mL), 1 h incubation at RT in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Figure 4 Animal Species Reactivity
Loading: Lysates/proteins at 15 μg per lane.
Antibodies: 2125 (2 μg/mL) or 2127 (2 μg/mL). 1 h incubation at RT in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Figure 5 Validation with MyD88 siRNA Knockdown
HeLa cells were transfected with control siRNAs (lane 1) or MyD88 siRNAs (lane 2)
Loading: 10 μg of HeLa whole cell lysates per lane.
Antibodies: 2127 (2 μg /mL), 1 h incubation at RT in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Figure 6 Immunofluorescence Validation of MyD88
Immunofluorescent analysis of 4% paraformaldehyde-fixed Jurkat cells labeling MyD88 with 2127 at 20 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red) and DAPI staining (blue).
Figure 6 Immunofluorescence Validation of MyD88 in Jurkat Cells
Immunofluorescent analysis of 4% paraformaldehyde-fixed Jurkat cells labeling MyD88 with 2127 at 20 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red) and DAPI staining (blue).
Figure 8 KO Validation of MyD88 in T cells (Rahman et al., 2011)
Splenocytes were isolated from a Myd88ΔT mouse in which MyD88 was specifically disrupted in T cells. T and B cells were FACS purified, and MyD88 expression was examined by Western blot with anti-MyD88 antibodies (2127). MyD88 expression was detected in Splenocytes and B cells, but not in T cells.
Figure 9 KO Validation in CD45-Thy1+ cells (Kim et al., 2017)
The expression of Myd88 protein was analyzed in CD45?Thy1+ intestinal mesenchymal cells and CD3+ intestinal
T cells, by immunoblotting with anti-Myd88 antibodies (2127). MyD88 expression was not detected in knockout cells.
Figure 10 KD Validation in Raw 264.7 cells (Altimeier et al., 2007)
The Transfection of RAW 264.7 cells with MyD88-specific siRNA
resulted in attenuation of MyD88 protein by Western blot analysis with anti-Myd88 antibodies (2127).
Figure 11 Immunoprecipitation Validation in HEK293 cells (Kawai et al., 2004)
HEK293 cells were transiently transfected with DYKDDDDK-IRF7. Ccell lysates were immunoprecipitated with control rabbit anti-mouse immunoglobulin serum (IgG) or anti-MyD88 (Ab1 and Ab2), followed by immunoblotting with anti-DYKDDDDK.